Adaptimmune Therapeutics Plc (ADAP) — Working Capital to Net Assets Ratio
Adaptimmune Therapeutics Plc (ADAP) has a Working Capital to Net Assets ratio of -37.5% as of June 2025. Working capital of $26.60 Million (current assets of $78.11 Million minus current liabilities of $51.51 Million) is measured against net assets of $-70.96 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Adaptimmune Therapeutics Plc (ADAP) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Adaptimmune Therapeutics Plc Working Capital to Net Assets (2011–2024)
This chart shows how Adaptimmune Therapeutics Plc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of June 2025, the ratio stands at -37.5%, reflecting working capital of $26.60 Million against net assets of $-70.96 Million USD. For the complete balance sheet picture, see Adaptimmune Therapeutics Plc assets under control.
Annual Working Capital to Net Assets for Adaptimmune Therapeutics Plc (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Adaptimmune Therapeutics Plc from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check ADAP asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 1043.5% | $123.64 Million | $11.85 Million | $188.17 Million | $64.53 Million | ▲ +702.4 pp |
| 2023 | 341.1% | $134.76 Million | $39.51 Million | $207.55 Million | $72.79 Million | ▲ +107.9 pp |
| 2022 | 233.1% | $190.87 Million | $81.88 Million | $255.37 Million | $64.50 Million | ▲ +61.8 pp |
| 2021 | 171.4% | $352.92 Million | $205.96 Million | $415.46 Million | $62.54 Million | ▲ +66.1 pp |
| 2020 | 105.2% | $359.08 Million | $341.23 Million | $398.15 Million | $39.07 Million | ▲ +35.6 pp |
| 2019 | 69.7% | $86.15 Million | $123.64 Million | $120.49 Million | $34.34 Million | ▼ -14.0 pp |
| 2018 | 83.7% | $206.66 Million | $246.88 Million | $231.09 Million | $24.44 Million | ▲ +6.9 pp |
| 2017 | 76.8% | $155.87 Million | $202.98 Million | $230.18 Million | $74.31 Million | ▼ -18.6 pp |
| 2016 | 95.4% | $158.48 Million | $166.14 Million | $198.75 Million | $40.27 Million | ▼ -8.0 pp |
| 2015 | 103.4% | $268.35 Million | $259.61 Million | $295.11 Million | $26.76 Million | ▲ +0.0 pp |
| 2014 | 103.4% | $268.35 Million | $259.61 Million | $295.11 Million | $26.76 Million | ▲ +62.7 pp |
| 2013 | 40.6% | $979.32K | $2.41 Million | $54.09 Million | $53.11 Million | ▼ -69.0 pp |
| 2012 | 109.7% | $-2.36 Million | $-2.16 Million | $1.60 Million | $3.97 Million | ▼ -67.8 pp |
| 2011 | 177.5% | $-223.04K | $-125.66K | $3.87 Million | $4.09 Million | — |